Holdings of Catalio Capital Management, LP
38 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 57.7 % of the equity sleeve
Sector breakdown
- Health care 20.7 %
- Materials 3.8 %
- Unattributed 75.5 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 92.2 %
- DK 6.6 %
- FR 1.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 36 | 413.6M $ | 92.24 % |
| 2 | DK | 1 | 29.5M $ | 6.59 % |
| 3 | FR | 1 | 5.3M $ | 1.17 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | Dianthus Therapeutics Inc | 560,308 | 47M $ | |
| 2 | Bridgebio Pharma Inc | 432,014 | 32.1M $ | |
| 3 | Ascendis Pharma A/S | 129,111 | 29.5M $ | |
| 4 | Bristol-Myers Squibb Co | 420,727 | 25.5M $ | |
| 5 | Syndax Pharmaceuticals Inc | 1,043,670 | 24.4M $ | |
| 6 | Gilead Sciences Inc | 163,905 | 22.8M $ | |
| 7 | Terns Pharmaceuticals Inc | 409,031 | 21.6M $ | |
| 8 | Soleno Therapeutics Inc | 577,808 | 19.3M $ | |
| 9 | Boston Scientific Corp | 299,318 | 18.8M $ | |
| 10 | Ultragenyx Pharmaceutical Inc | 850,797 | 17.8M $ | |
| 11 | Incyte Corp | 182,101 | 17.1M $ | |
| 12 | Cytokinetics Inc | 215,501 | 14.2M $ | |
| 13 | Natera Inc | 70,907 | 14.2M $ | |
| 14 | Corvus Pharmaceuticals Inc | 891,933 | 13M $ | |
| 15 | Structure Therapeutics Inc | 255,379 | 12.3M $ | |
| 16 | Mineralys Therapeutics Inc | 439,041 | 11.9M $ | |
| 17 | Edwards Lifesciences Corp | 144,607 | 11.6M $ | |
| 18 | VeraDermics Inc | 173,582 | 11M $ | |
| 19 | Adaptive Biotechnologies Corp | 722,784 | 10M $ | |
| 20 | HeartFlow Inc | 403,588 | 9.8M $ | |
| 21 | KalVista Pharmaceuticals Inc | 426,551 | 8.6M $ | |
| 22 | Disc Medicine Inc | 122,978 | 7.9M $ | |
| 23 | Septerna Inc | 294,360 | 7.1M $ | |
| 24 | Abivax SA | 47,193 | 5.3M $ | |
| 25 | Dyne Therapeutics Inc | 282,954 | 5.1M $ | |
| 26 | Eledon Pharmaceuticals Inc | 1,639,816 | 5.1M $ | |
| 27 | Karyopharm Therapeutics Inc | 897,709 | 5M $ | |
| 28 | Supernus Pharmaceuticals Inc | 62,019 | 3.2M $ | |
| 29 | Protara Therapeutics Inc | 580,024 | 3M $ | |
| 30 | Phathom Pharmaceuticals Inc | 247,767 | 2.8M $ | |
| 31 | Tyra Biosciences Inc | 67,285 | 2.6M $ | |
| 32 | Immunocore Holdings PLC | 84,352 | 2.5M $ | |
| 33 | Fractyl Health Inc | 5,491,866 | 2.5M $ | |
| 34 | Hyperfine Inc | 1,320,041 | 1.4M $ | |
| 35 | METAGENOMI THERAPEUTICS INC | 528,993 | 708.9K $ | |
| 36 | AtaiBeckley Inc | 196,858 | 696.9K $ | |
| 37 | SENSEI BIOTHERAPEUTICS INC | 14,718 | 463.9K $ | |
| 38 | Outset Medical Inc | 118,279 | 454.2K $ | |